Article

OBJECTIVE: To generate practice-based evidence of outcomes in an
interdisciplinary spasticity management clinic using practical application of the
Goal Attainment Scale (GAS). DESIGN: Retrospective chart review. PATIENTS: A
total of 225 adult patients who were referred for spasticity management at a
tertiary rehabilitation hospital and returned for follow-up between 2010 and 2013. METHODS: GAS scores were determined for all patients.
GAS T-scores were
evaluated based on age;
sex; diagnosis; International Classification of
Functioning, Disability and Health (ICF) domain; body region affected; and site
of botulinum neurotoxin injection. RESULTS: The distribution of GAS outcomes did
not vary by age, sex or diagnosis. The overall GAS T-score for the clinic was
47.7, which is consistent with appropriate goal setting. GAS T-scores did not
vary by diagnosis or ICF domain. Significant intervention effects were identified
for botulinum neurotoxin, with improvements in GAS T-scores for treatment
targeted to both upper and lower limb muscles, compared with no botulinum
neurotoxin, across diagnoses and ICF domains. CONCLUSION: The GAS is a useful
patient-centred outcome measure that can be practically applied in the clinical
setting for a heterogeneous population with diverse goals. Botulinum neurotoxin
treatment in this setting was associated with improved goal attainment relating
to multiple ICF domains.

Langue : ANGLAIS